Abstract:Objective:To investigate the onset of hepatic artery-portal vein shunts (HAPVS) in primary liver cancer (PLC) pa-tients through digital subtraction angiography (DSA) and to devise a suitable strategy for treating both lesions and shunt tracts. In the process, the therapeutic effect on such patients can be enhanced. Methods:A total of 769 PLC patients who accepted transarterial che-moembolization (TACE) were analyzed retrospectively. We examined the image characteristics of 112 cases with HAPVS based on shunt type. For patients with middle or severe fistula, we initially attempted to overpass the fistula. Then, we either embolized the tumor lesions or merely provided chemotherapy to the patients. For patients with mild peripheral fistula, we embolized the tumor and fistula si-multaneously. Then, the accompanying arterial-vein shunt and portal vein tumor thrombus (PVTT) were handled at the same time. Re-sults: DSA findings showed that portal veins were observed in the early stage of angiography. A total of 52 of the 112 cases with HAPVS involved mild shunts, 34 exhibited moderate shunts, and 26 reported severe shunts. Among these cases, 31 involved central-and central peripheral-type artery-portal vein fistula, whereas 81 involved peripheral-type artery-portal vein fistula. Seven cases were examined in combination with hepatic artery-liver vein shunts, and 50 cases were investigated in conjunction with PVTT. Tumor embo-lization was successful in 101 cases (90.1%). Moreover, catheters successfully overpassed shunt tracts and embolized the tumors in 48 cases (42.9%). Shunt tracts were successfully closed in 74 cases (66.1%), and no serious complication was observed. Conclusion:Pe-ripheral-type artery-portal vein fistula and mild-to-moderate shunts were easier to close than central-type artery-portal vein fistula and severe shunts were. Tumor embolization and shunt closure were successful in most patients. Therefore, TACE is a safe and reliable method for treating HAPVS in PLC.

Progress of Interventional Theraphy in Primary Liver Cancer with Portal Vein Tumor Thrombus

Prolong Overall Survival Rate for Patients with Liver Cancer Receiving Double Interventional Therapy

Treatment Options for Portal Hypertension in the Era of Liver Transplantation

The Role of Interventional Treatment on Hepatocellular Carcinoma Combined with Portal Vein Tumor Thrombosis

Recent advances on the treatment of hepatocellular carcinoma with portal vein tumor thrombus

Interventional therapy for primary liver cancer complicated with hepatic arteriovenous fistula

Primary hepatocellular carcinoma associated with portal vein tumor thrombus: report of one case with survival over 5 years and review of literature

The Efficacy of Intravessel Obstructive Therapy in Primary Liver Cancer Patients Complicated with Intrahepatic Arteriovenous Fistula

Current Status of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation in Treatment of Primary Liver Cancer

Surgical Treatment for Primary Liver Cancer with Portal Vein Tumor Thrombus(13 Cases Report)

Intervetional Therapy for Portal Vein Occlusion after Liver Tansplantation

TACE for the treatment of primary hepatocellular carcinoma associated with portal vein tumor thrombus: recent progress in research

Clinical Analysis of Interventional Therapies for Primary Liver Cancer

The Progress in Diagnosis and Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

Clinical Studies Of Laser Ablation In Treatment Of Primary Liver Carcinoma-Associated Portal Vein Tumor Thrombus

Interventional treatment for complications after liver transplantation

Interventional Therapy of Primary Hepatocellular Carcinoma Through Hepatic Artery and Portal Vein

Imaging characteristics and intervention therapy for hepatic artery-portal vein shunts in patients with primary liver carcinoma

The present status of treatment in primary hepatic cancer complicated with portal venous tumor emboli

Therapeutic effect of postoperative transarterial chemoembolization and portal vein chemotherapy on primary liver cancer with portal vein tumor thrombus

The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus